Facial Injectables Market - Growth, Trends , COVID-19 Impact , and Forecasts (2022 - 2027)

The Facial Injectables Market is segmented by Type (Wrinkle Relaxers (Botulinum Toxin) and Dermal Fillers (Collagen, Hyaluronic Acid, Fat Injection, Polylactic Acid, Polymethyl-methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, Other Dermal Fillers), Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Other Application), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

facial injectables market size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 12.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Facial Injectables market is expected to register a CAGR of nearly 12.2% during the forecast period.

The outbreak of COVID-19 resulted in decreased public mobility and has also impacted the therapeutic and surgical industry significantly, as the surgical procedures and screening programs, which are non-immediate and are being postponed to decrease the burden on healthcare infrastructure. For instance, according to the study published in the British Journal of Surgery, in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide will be canceled or postponed 2020. In addition, rising cases of COVID–19 in the countries are expected to have a short-term impact on surgical rates of cosmetic procedures. The short-term effects on the surgical segment are less prominent. However, the adverse impacts of COVID-19 on the global economy can have significant indirect effects on the surgical segment of the market.

The propelling factors for the growth of the facial injectables market include the rising aesthetic consciousness and number of cosmetic procedures, the introduction of cost-effective facial injectable, and the aging population.

The cosmetic industry is found to be booming in the current decade and has undergone an estimated three-fold increase in turnover over the last few decades. In particular, there has been an increase in the total number of non-surgical therapies, such as injections of wrinkle relaxers and dermal fillers. This trend is primarily due to the advantages of technologies, such as low recovery time, less risk of infections, no blood loss, and the overall reduction in procedural costs. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) published Global Survey Results 2020 report, a total of 10,129,528 cosmetic surgical procedures were performed in 2020, and the top five surgical procedures included breast augmentation (1,624,281), liposuction (1,525,197), eyelid surgery (1,225,540), abdominoplasty (765,248), and rhinoplasty (852,554).

In addition, there is a consistent rise in the geriatric population that helps to boost the market growth. For instance, according to the World Health Organization, by 2030, 1 out of every 6 people on the planet will be 60 years old or older. The number of people aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of people aged 60 and above will get double to reach 2.1 billion. Between 2020 and 2050, the number of people aged 80 and above is expected to triple, reaching 426 million. Furthermore, technological advancements are also helping in the growth of the market.

The market players are adopting various strategies such as product launches, developments, collaborations, partnerships, acquisitions and expansions to increase market share. For instance, in February 2019, the United States Food and Drug Administration (FDA) approved, Jeuveau which is found to be effective in reducing wrinkles. Thus, owing to above mentioned factors it is likely to drive the market growth. However, factors such as side-effects of available products limiting adoption and lack of reimbursement policies supporting cosmetic procedures are likely to impede market growth in near future.

Scope of the Report

As per the scope of the report, facial injectables aid in rejuvenating the facial skin by reducing wrinkles, raising scar depressions, and enhancing the lips. Facial injectables are products that include collagen fillers, hyaluronic acid fillers, and synthetic fillers, such as calcium hydroxylapatite. The use of injectable products, such as hyaluronic acid increases skin hydration, improves skin, and protects from UV damage and has relatively low side effects. The facial injectables market is segmented by Type (Wrinkle Relaxers (Botulinum Toxin) and Dermal Fillers (Collagen, Hyaluronic Acid, Fat Injection, Polylactic Acid, Polymethyl-methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, Other Dermal Fillers), Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Other Application), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type
Wrinkle Relaxers
Botulinum Toxin
Dermal Fillers
Collagen
Hyaluronic Acid
Fat Injection
Polylactic Acid
Polymethyl-methacrylate Microspheres (PMMA)
Calcium Hydroxylapatite
Other Dermal Fillers (Polyalkylimide etc.)
By Application
Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Hyaluronic Acid Segment is Expected to Hold Significant Share Over the Forecast Period

Some of the factors that are responsible for Hyaluronic acid segment growth include known for its ability to store moisture in the skin, thus making the skin look healthier, a moisture-binding characteristic that helps enhance and maintain the vital moisture responsible for the plumpness of the facial skin. The increasing demand for aesthetic procedures and an increasing number of facial procedures are boosting the segment growth.

A research article by Matt Spick et al., published in September 2020, found that most people infected with SARS-COV-2 coronavirus are likely to develop dyslipidemia and changes in their sebum liposome that can lead to premature aging of the skin in the long term which is expected to boost the market growth in coming years.

Hyaluronic acid has major benefits as it increases hydration, improves elasticity, and reverses free radical damage that protects from UV damage. These factors help in driving the overall market for hyaluronic acid. It is also seen that the demand for hyaluronic acid is increasing significantly, which is expected to provide consistent growth in the coming years in the studied market.

The market players are adopting various strategies such as product launches, developments, collaborations, partnerships, acquisitions and expansions to increase market share. For instance, in June 2020, AbbVie Inc., (Allergan Plc) received approval from United States Food and Drug Administration (FDA) for JUVÉDERM VOLUMA XC for the augmentation of the chin region in adults over the age of 21.

In addition, in August 2020, Revance launched the RHA (resilient hyaluronic acid) collection of fillers. The resilient hyaluronic acid fillers are designed to adapt to facial dynamics and represent the first step in the line of products for aesthetic practices. Thus, owing to above mentioned factors it is likely to drive the segment growth over the forecast period.

Injectable Procedures

North America Dominates the Market and Expected to do Same in the Forecast Period

Some of the factors that are driving the market growth in the North America region include higher awareness about aesthetic surgical procedures, technological advancements in cosmetic procedures, the presence of key market players, and the increasing geriatric population and demand for non-invasive aesthetic procedures.

According to the American Society of Plastic Surgeons (ASPS), in 2020, plastic surgeons stopped performing elective surgical procedures for an average of 8.1 weeks 2020 due to COVID-19, or 15% of the year, which indicates the decline in the total number of procedures performed. Moreover, in 2020, minimally invasive cosmetic procedures decreased slightly more than surgical procedures (16% vs. 14%) during stay-at-home orders, dropping for the first time in four years.

In Canada, the growing geriatric population is also fueling the growth. As per the World Population Ageing Report, in Canada, there were around 6.602 million people aged over 65 years in 2019, and the number is estimated to reach 11.436 million by 2050. The demand for aesthetic fillers is expected to increase due to increased attention on facial aesthetics among this population.

According to the American Society of Plastic Surgeons, in 2020, 13,281,235 cosmetic minimally-invasive procedures were performed in the United States, out of which 4,401,536 were botulinum toxin procedures. It was the number one non-surgical procedure found in 2020. However, ASPS anticipates a decrease in the total number of cosmetic procedures in 2020 due to the COVID-19 pandemic, but it forecasts strong demand for treatments as practices rereopensor in-office procedures. As per the same source, as of 2019, around 2,160,578 Hyaluronic acid cosmetic minimally-invasive procedures have been carried out in the United States.

The presence of key players in the United States that are launching new products in the market, gives an edge to the country in the global market. In January 2020, Revance Therapeutics, reported that transformative aesthetics portfolio transaction with exclusive United States distribution agreement of Food and Drug Administartion approved dermal fillers from Teoxane SA. TEOXANE SA RHA portfolio is one of the first FDA-approved dermal fillers for correction of dynamic wrinkles. In the future, with above mentioned factors it is expected to witness rapid growth over the forecast period.

Facial Injectables Market - Growth Rate by Region

Competitive Landscape

The Facial Injectables Market is moderately competitive. The key players present in the market are making collaborations and product launch strategies in order to address the unmet aesthetic needs. Thereby, providing the physicians with new and better options, as well as augmenting the growth of the facial injectables market. The companies are also focusing on expanding their presence in the emerging markets and also trying to maintain strong distributor relationships. Some of the market players include AbbVie Inc (Allergan Plc), Ipsen SA, Medytox Inc., Merz Pharma, Sinclair Pharma Plc, among others.

Recent Developments

  • In February 2022, Merz Aesthetics has Launched Radiesse (+) as First and Only Aesthetic Injectable to Improve Moderate to Severe Loss of Jawline Contour
  • In September 2021, Aesthetics innovators launched two innovative new injectables into the aesthetics sphere MaiLi, a hyaluronic acid (HA) dermal filler which uses less product than traditional fillers, and Lanluma, industry-first collagen stimulating filler for the body.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Aesthetic Consciousness and Number of Cosmetic Procedures

      2. 4.2.2 Introduction of Cost-effective Facial Injectable

      3. 4.2.3 Ageing Population

    3. 4.3 Market Restraints

      1. 4.3.1 Side-effects of Available Products Limiting Adoption

      2. 4.3.2 Lack of Reimbursement Policies Supporting Cosmetic Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Type

      1. 5.1.1 Wrinkle Relaxers

        1. 5.1.1.1 Botulinum Toxin

      2. 5.1.2 Dermal Fillers

        1. 5.1.2.1 Collagen

        2. 5.1.2.2 Hyaluronic Acid

        3. 5.1.2.3 Fat Injection

        4. 5.1.2.4 Polylactic Acid

        5. 5.1.2.5 Polymethyl-methacrylate Microspheres (PMMA)

        6. 5.1.2.6 Calcium Hydroxylapatite

        7. 5.1.2.7 Other Dermal Fillers (Polyalkylimide etc.)

    2. 5.2 By Application

      1. 5.2.1 Facial Line Correction

      2. 5.2.2 Lip Augmentation

      3. 5.2.3 Face Lift

      4. 5.2.4 Acne Scar Treatment

      5. 5.2.5 Lipoatrophy Treatment

      6. 5.2.6 Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc (Allergan Plc)

      2. 6.1.2 Anika Therapeutics Inc.

      3. 6.1.3 Ipsen SA

      4. 6.1.4 Medytox Inc.

      5. 6.1.5 Merz Pharma

      6. 6.1.6 Galderma Pharma SA

      7. 6.1.7 Sanofi SA

      8. 6.1.8 Sinclair Pharma Plc

      9. 6.1.9 Suneva Medical Inc.

      10. 6.1.10 Alphaeon Corporation (Teoxane Laboratories)

      11. 6.1.11 Bloomage Biotechnology (Laboratories Vivacy SAS)

      12. 6.1.12 SciVision Biotech Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Facial Injectables Market market is studied from 2019 - 2027.

The Global Facial Injectables Market is growing at a CAGR of 12.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

AbbVie Inc (Allergan Plc), Ipsen SA, Medytox Inc., Merz Pharma, Sinclair Pharma Plc are the major companies operating in Global Facial Injectables Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!